Peptide E from Bifidobacterium adolescentis LA20-k9 fermentation inhibits feline renal cellular senescence via the SMAD7/p-SMAD3/IL6-CXCL8 axis
Ontology highlight
ABSTRACT: Aging is an inevitable biological phenomenon that drives progressive functional decline at cellular and tissue levels, with chronic kidney disease (CKD) affecting up to 80% of cats over 15 years of age. Probiotic-derived metabolites hold anti-aging promise, but their renal protective mechanisms remain largely undefined. In this study, we investigated the anti-senescence effects of fermented brown algae extracts from Bifidobacterium adolescentis LA20-K9 (LA20FM) on feline kidney cells. Both the LA20FM<3 kDa and LA20FM>30 kDa molecular weight fractions mitigated doxorubicin-induced senescence, as evidenced by reduced SA-β-gal activity and decreased CDKN1A/CDKN2A expression. Peptide E, which was isolated from the LA20FM<3 kDa fraction, was identified as the principal bioactive component. RNA-sequencing revealed that peptide E downregulated senescence-associated genes, including IL6, CXCL8, GDF15, and KRT15, while upregulating the anti-senescence gene SMAD7. Mechanistically, peptide E enhanced SMAD7 expression, which in turn suppressed SMAD3 phosphorylation and consequently reduced IL6 and CXCL8 transcription. Crucially, SMAD7 knockdown completely abrogated these protective effects. Collectively, our findings identify peptide E as a novel bioactive peptide that antagonizes renal cellular senescence via the SMAD7/p-SMAD3/IL6-CXCL8 axis, offering a potential therapeutic candidate for age-related kidney dysfunction in felines.
ORGANISM(S): Felis catus
PROVIDER: GSE337653 | GEO | 2026/07/07
REPOSITORIES: GEO
ACCESS DATA